tirzepatide discontinuation weight regain study Many adults stop GLP-1 therapy within a year with low restart rates, analysis finds What Happens When You Stop

Evolutionary adaptation of probiotics in the gut: selection pressures, optimization strategies, and regulatory challenges

The genetics of intervertebral disc degeneration

Details of clinical codes for eligibility criteria, exposure, outcomes, and confounders are in Supplementary Table S1 in the Supplementary Appendix

A second study tested whether CIT could enhance postprandial muscle blood flow, microvascular perfusion, and muscle protein synthesis (MPS) in elderly men following unilateral resistance exercise

REFERENCES 1.Randall P

When weight goes down, we see improvements in blood pressure and cholesterol, which means they may not need those other meds anymore. By 2026, the industry has realized that these drugs are not just a product: they are the foundational platform for the next era of chronic disease management.